Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "accounting"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
1
-
8
of
8
Search:
'"accounting"'
,
query time: 0.07s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolera...
Published 2020
CADTH
Read Now
2
Pharmacoeconomic review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolera...
Published 2020
CADTH
Read Now
3
Optimal warfarin management for prevention of thromboembolic events in patients with atrial fibrillation
Published 2011
Canadian Agency for Drugs and Technologies in Health
Read Now
4
Pharmacoeconomic report: Apomorphine hydrochloride (Kynmobi) (Sunovion Pharmaceuticals Canada Inc.) : indication: the acute, intermittent treatment of "OFF" episodes in patients wi...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... uncertainties remain, as the model did not
account
for the need for subsequent or adjunctive treatments...
”
Read Now
5
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... populations as distinct populations. CADTH also
accounted
for limitations by including relevant comparators...
”
Read Now
6
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... populations as distinct populations. CADTH also
accounted
for limitations by including relevant comparators...
”
Read Now
7
Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...
Published 2019
CADTH
Read Now
8
Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...
Published 2019
CADTH
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
140 - Specific philosophical schools
2
610 - Medicine & health
1
Language
English
Collection
National Center for Biotechnology Information
8
Author
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22accounting%22&type=AllFields
Send by Email
×
Loading...